Skip to main content

JPMORGAN CHASE & CO

Position in LXEO — Lexeo Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in LXEO

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$534,754
+$238,235 QoQ
Shares Held
93,163
+212.0% QoQ
Ownership
0.119%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 66% Shared 0% None 34%

Common Shares in LXEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. LXEO ranks #187 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LXEO

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $534,754 93,163
2025-12-31 $296,519 29,861
2025-09-30 $95,343 14,359
2025-06-30 $55,274 13,750
2025-03-31 $47,815 13,780
2024-12-31 $87,980 13,371
2024-09-30 $92,912 10,278
2024-06-30 $69,982 4,363
2024-03-31 $93,342 5,953
2023-12-31 $1,503 112